Ankylosing Spondylarthritis
2 clinical trials · Condition
◉ Watch Ankylosing Spondylarthritis
| Record | Firm | Date |
|---|---|---|
| Yuflyma® (Adalimumab), Patient Experience After Switching (NCT05427942) | Celltrion HealthCare France | 2022-06-03 |
| Ankylosing Spondylitis and Antiphospholipid Antibodies (NCT02809300) | CHU de Reims | 2015-11-01 |
Track Ankylosing Spondylarthritis automatically
Every clearance here is in the API, with alerts when new ones post.